| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biorestorative Therapies, Inc. (BRTX) has 2 insiders with recent SEC Form 4 filings, including 13 buys and 1 sell. BRTX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 187.5K | $34.9K | - | |
| VP | 171.4K | $31.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2022 | Silva Francisco48 | VP Of Research And Development | Sell | 3,958 | $3.39 | $13,409.70 | -2.4% | -14.3% | -24.7% | |
| Jul 13, 2022 | Broadrick Dale60 | 10% Owner | Buy | 1,200 | $3.01 | $3,610.99 | +0.1% | +14.1% | +17.0% | |
| Jul 12, 2022 | Alstodt Lance55 | President, CEO, Cob | Buy | 700 | $2.95 | $2,065.00 | +0.4% | +16.1% | +3.7% | |
| Jun 30, 2022 | Alstodt Lance55 | President, CEO, Cob | Buy | 1,100 | $3.10 | $3,407.91 | +0.6% | -4.1% | +49.5% | |
| Jun 30, 2022 | Broadrick Dale60 | 10% Owner | Buy | 1,900 | $3.08 | $5,849.91 | +0.6% | -4.1% | +49.5% | |
| Jun 21, 2022 | Broadrick Dale60 | 10% Owner | Buy | 700 | $3.79 | $2,649.94 | +0.1% | -21.1% | +56.8% | |
| Jun 16, 2022 | Alstodt Lance55 | President, CEO, Cob | Buy | 600 | $3.73 | $2,238.00 | +0.3% | -12.9% | +72.2% | |
| Jun 16, 2022 | Broadrick Dale60 | 10% Owner | Buy | 3,200 | $3.77 | $12,074.88 | +0.5% | -12.9% | +72.2% | |
| Jun 15, 2022 | Kristal Robert Eugene | Chief Financial Officer | Buy | 194 | $3.61 | $700.34 | +2.5% | -13.9% | +55.7% | |
| Jun 15, 2022 | Alstodt Lance55 | President, CEO, Cob | Buy | 700 | $3.68 | $2,577.54 | +0.4% | -13.9% | +55.7% |